Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study

[1]  Jane S. Paulsen,et al.  In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease , 2004, Neurology.

[2]  Mario Mascalchi,et al.  Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. , 2004, Radiology.

[3]  E. Vandenbussche,et al.  Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation , 2004, Journal of Neurology.

[4]  J. Brandt,et al.  Onset and rate of striatal atrophy in preclinical Huntington disease , 2004, Neurology.

[5]  C. Ross.  Huntington's Disease New Paths to Pathogenesis , 2004, Cell.

[6]  Sarah A. J. Reading,et al.  Functional brain changes in presymptomatic Huntington's disease , 2004, Annals of neurology.

[7]  J R Hodges,et al.  Profile of cognitive progression in early Huntington’s disease , 2003, Neurology.

[8]  N Makris,et al.  Evidence for more widespread cerebral pathology in early HD , 2003, Neurology.

[9]  V. Menon,et al.  White matter tract alterations in fragile X syndrome: Preliminary evidence from diffusion tensor imaging , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[10]  D. W Loring,et al.  Now you see it, now you don’t: statistical and methodological considerations in fMRI , 2002, Epilepsy & Behavior.

[11]  Susumu Mori,et al.  Fiber tracking: principles and strategies – a technical review , 2002, NMR in biomedicine.

[12]  Jason Brandt,et al.  Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals , 2002, Journal of the International Neuropsychological Society.

[13]  Karl J. Friston,et al.  Distributional Assumptions in Voxel-Based Morphometry , 2002, NeuroImage.

[14]  C D Good,et al.  The distribution of structural neuropathology in pre-clinical Huntington's disease. , 2002, Brain : a journal of neurology.

[15]  G. Halliday,et al.  Pyramidal Cell Loss in Motor Cortices in Huntington's Disease , 2002, Neurobiology of Disease.

[16]  P. Bartolomeo,et al.  Retest effects and cognitive decline in longitudinal follow-up of patients with early HD , 2001, Neurology.

[17]  G J Barker,et al.  Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. , 2001, Brain : a journal of neurology.

[18]  M. Symms,et al.  Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. , 2001, Brain : a journal of neurology.

[19]  P G Bhide,et al.  Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain , 2001, Journal of neuropathology and experimental neurology.

[20]  R H Myers,et al.  Quantitative neuropathological changes in presymptomatic Huntington's disease , 2001, Annals of neurology.

[21]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[22]  G. Pearlson,et al.  Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[23]  C. Pierpaoli,et al.  Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: application to white matter fiber tract mapping in the human brain , 1999, Magnetic resonance in medicine.

[24]  G. M. Halliday,et al.  Regional Specificity of Brain Atrophy in Huntington's Disease , 1998, Experimental Neurology.

[25]  G. Pearlson,et al.  Frontal lobe volume in patients with Huntington's disease , 1998, Neurology.

[26]  P. Basser,et al.  Toward a quantitative assessment of diffusion anisotropy , 1996, Magnetic resonance in medicine.

[27]  J. Lowe,et al.  The cortical neuritic pathology of Huntington's disease , 1995, Neuropathology and applied neurobiology.

[28]  P. V. van Zijl,et al.  Diffusion Weighting by the Trace of the Diffusion Tensor within a Single Scan , 1995, Magnetic resonance in medicine.

[29]  P. Basser,et al.  Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.

[30]  R H Myers,et al.  Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus , 1991, Journal of neuropathology and experimental neurology.

[31]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[32]  J. Talairach,et al.  Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .

[33]  J. Vonsattel,et al.  Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.

[34]  A. T. Ross.  Policies of the American Board of Psychiatry and Neurology respecting neurology , 1963, Neurology.

[35]  L. Goldstein,et al.  Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways. , 2005, Archives of neurology.

[36]  H. Heinsen,et al.  Cortical and striatal neurone number in Huntington's disease , 2004, Acta Neuropathologica.

[37]  Alan C. Evans,et al.  Automated labeling of the human brain: A preliminary report on the development and evaluation of a forward‐transform method , 1997, Human brain mapping.

[38]  P. Basser,et al.  MR diffusion tensor spectroscopy and imaging. , 1994, Biophysical journal.

[39]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .